Capital World Investors 13D and 13G filings for Biohaven Pharmaceutical Holding Company Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-06-10 2:57 pm Sale |
2022-06-10 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
Capital World Investors | 3,446,156 4.900% |
-3,629,358 (-51.29%) |
Filing |
| 2022-05-10 11:56 am Purchase |
2022-05-10 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
Capital World Investors | 7,075,514 10.000% |
897,505 (+14.53%) |
Filing |
| 2022-02-11 2:48 pm Purchase |
2022-02-14 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
Capital World Investors | 6,178,009 9.400% |
1,528,561 (+32.88%) |
Filing |
| 2021-02-16 2:04 pm Purchase |
2021-02-16 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
Capital World Investors | 4,649,448 7.800% |
4,649,448 (New Position) |
Filing |